Literature DB >> 18510607

The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis.

Joel E Mawdsley1, David G Jenkins, Marion G Macey, Louise Langmead, David S Rampton.   

Abstract

OBJECTIVES: Hypnotherapy is effective in several diseases with a psychosomatic component. Our aim was to study the effects of one session of hypnosis on the systemic and rectal mucosal inflammatory responses in patients with active ulcerative colitis (UC).
METHODS: In total, 17 patients with active UC underwent a 50-min session of gut-focused hypnotherapy. Before and after each procedure, the systemic inflammatory response was assessed by serum interleukin (IL)-6 and IL-13 concentrations, tumor necrosis factor-alpha (TNF-alpha) and IL-6 production by lipopolysaccharide (LPS)-stimulated whole blood, leukocyte count, natural killer (NK) cell number, platelet activation, and platelet-leukocyte aggregate formation. Rectal inflammation was assessed by mucosal release of substance P (SP), histamine, IL-13 and TNF-alpha, reactive oxygen metabolite production, and mucosal blood flow. Eight patients with active UC underwent a control procedure.
RESULTS: Hypnosis decreased pulse by a median 7 beats per minute (bpm) (P= 0.0008); it also reduced the median serum IL-6 concentration by 53% (P= 0.001), but had no effect on the other systemic variables assessed. Hypnosis reduced rectal mucosal release of SP by a median 81% (P= 0.001), histamine by 35% (P= 0.002) and IL-13 by 53% (P= 0.003), and also, blood flow by 18% (P= 0.0004). The control protocol had no effect on any of the variables assessed.
CONCLUSIONS: Hypnosis reduced several components of the systemic and mucosal inflammatory response in active ulcerative colitis toward levels found previously in the inactive disease. Some of these effects may contribute to the anecdotally reported benefits of hypnotherapy and provide a rationale for controlled trials of hypnotherapy in UC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18510607     DOI: 10.1111/j.1572-0241.2008.01845.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  24 in total

Review 1.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

2.  Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis.

Authors:  L Keefer; T H Taft; J L Kiebles; Z Martinovich; T A Barrett; O S Palsson
Journal:  Aliment Pharmacol Ther       Date:  2013-08-19       Impact factor: 8.171

Review 3.  Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease.

Authors:  Stefanie Joos
Journal:  Chin J Integr Med       Date:  2011-06-10       Impact factor: 1.978

Review 4.  Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance.

Authors:  Whitney Duff; Natasha Haskey; Gillian Potter; Jane Alcorn; Paulette Hunter; Sharyle Fowler
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

5.  Treatment of psychological co-morbidities in common gastrointestinal and hepatologic disorders.

Authors:  Antonina A Mikocka-Walus
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-04-06

Review 6.  Psychological Considerations and Interventions in Inflammatory Bowel Disease Patient Care.

Authors:  Tiffany H Taft; Sarah Ballou; Alyse Bedell; Devin Lincenberg
Journal:  Gastroenterol Clin North Am       Date:  2017-10-03       Impact factor: 3.806

Review 7.  Effectiveness of Stress-Reducing Interventions on the Response to Challenges to the Immune System: A Meta-Analytic Review.

Authors:  Lemmy Schakel; Dieuwke S Veldhuijzen; Paige I Crompvoets; Jos A Bosch; Sheldon Cohen; Henriët van Middendorp; Simone A Joosten; Tom H M Ottenhoff; Leo G Visser; Andrea W M Evers
Journal:  Psychother Psychosom       Date:  2019-08-06       Impact factor: 17.659

Review 8.  Narcotic bowel syndrome and opioid-induced constipation.

Authors:  Eva Szigethy; Marc Schwartz; Douglas Drossman
Journal:  Curr Gastroenterol Rep       Date:  2014-10

Review 9.  Refractory inflammatory bowel disease-could it be an irritable bowel?

Authors:  Jie Meng; Anurag Agrawal; Peter J Whorwell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-11       Impact factor: 46.802

10.  Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity.

Authors:  Yu You; Jian-Jiang Fu; Jun Meng; Guo-Dong Huang; Yu-Hui Liu
Journal:  Dig Dis Sci       Date:  2008-11-26       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.